On Jan. 28, Stryker Corp. announced plans to sell its U.S. spinal implant business to investment firm Viscogliosi Brothers. Though Stryker has a major share in the U.S. spine and orthopedic market, ...
Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.
Truist raised the firm’s price target on Stryker (SYK) to $413 from $409 and keeps a Hold rating on the shares. The company remains a top-tier ...
Notably, Stryker was named the most admired medtech company in the world. Another major orthopedic and spine device manufacturer, Medtronic, also earned a spot. 1. Stryker Corp.
Stryker Corporation (NYSE:SYK), a leading player in the medical technology industry with a substantial market capitalization of $149 billion, has been making waves with its strong financial ...
The stock's fall snapped a three-day winning streak.
Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2024: Fourth Quarter Results Reported net sales increased 10.7% ...
MemorialCare Long Beach Medical Center is the first hospital in California to add Stryker's Q Guidance system with Spine Guidance software, according to a Jan.